Layoff News
Myraid Pharmaceuticals Cutting 21 Positions
By victor | Dated: 06-08-2010
Myriad Pharmaceuticals announced it is ending its HIV maturation program and will cut 21 positions. The company plans to shift its focus from HIV maturation to its oncology pipeline.The Associated Press reports Myriad had 181 full-time employees as of Sept. 1, 2009.
Chief Executive Adrian Hobden said in a statement. “After conducting an exhaustive review of our development portfolio and business operations, we have decided to refocus our clinical efforts on oncology, where we believe we can maximize the return on our investments.”
The drug-development company expects to incur a $1.2 million charge related to the job cuts. The latest round of layoffs brings the total number to 30 since last July.
Myriad is currently seeking partners in its bid to acquire rival drug developer Javelin Pharmaceuticals. In April, the deal fell through when Hospira Inc. came in with a higher offer.
Career Connect (From our other career blogs):
- Employment News (Sponsored by EmploymentSpectator)
- Following Your Passion-Literally! (Sponsored by iamnotastalker.com)
- Job Search Advice from the CEO of TravelingCrossing (Sponsored by aharrisonbarnes.com)
- Layoff News (Sponsored by LayOffWatch)
Testimonial of the Week
EmploymentCrossing is great because it brings all of the jobs to one site. You don't have to go all over the place to find jobs.
- Kim Bennett Iowa,
Sign Up now
Only TravelingCrossing consolidates every job it can find in the domain and puts all of the job listings it locates in one place.
- We have more jobs than any other job board.
- We list jobs you will not find elsewhere that are hidden in small regional publications and employer websites
- We collect jobs from more than 4,429,376 websites and post them on our site.
- We are private, and therefore far fewer people are applying for the jobs on our site than are applying for those on public job boards.
